The type 2 diabetes drug Avandia, the subject of thousands of lawsuits, will get a new warning label and medication guide, according to manufacturer GlaxoSmithKline. The new label will provide information about tighter FDA restrictions on the drug and warn of potential heart failure linked to the drug.Read More »
Litigation over the anti-seizure drug Dilantin has developed into a smaller-scale mass tort, with dozens of suits claiming that it causes horrendous and life-threatening skin burns.Read More »
A four-lawyer firm won a jury verdict of over $21 million against the manufacturer of a self-retracting lifeline that failed when an iron worker wearing the lifeline was struck by a load of aluminum plates while working on a raised worksite in downtown Omaha, Neb.Read More »
When an idealistic associate suggested his firm take the case of a black high school senior who was beaten up by two police officers in southeast Texas after he was arrested for a traffic violation, Robert Luke needed to be ...Read More »
A defendant who lost a motion seeking summary judgment based on qualified immunity may not appeal that decision post-trial. See “Summary judgment can’t be appealed post-trial” U.S. Supreme Court. Ortiz v. Jordan, No. 09-737. Jan. 24, 2011. Lawyers USA No. ...
Tagged with: summary judgmentRead More »